Financhill
Sell
29

ADVM Quote, Financials, Valuation and Earnings

Last price:
$4.65
Seasonality move :
20.2%
Day range:
$4.61 - $4.89
52-week range:
$4.61 - $29.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.68x
Volume:
276.1K
Avg. volume:
270.5K
1-year change:
-40.01%
Market cap:
$98.6M
Revenue:
$3.6M
EPS (TTM):
-$6.01

Earnings Data

Next earnings date for ADVM
Mar 18
2025
Most recent earnings per share
-$1.30
Beat by $0.00
(Nov 4/2024)
Consensus Estimate
-$1.30
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADVM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/18/2025 Q4 -- -- -- -$1.39 --
11/04/2024 Q3 $62.5K $1M -$1.30 -$1.30 $0.00
08/12/2024 Q2 $66.3K -- -$0.89 -$1.47 $0.58
05/09/2024 Q1 $72.9K -- -$1.50 -$1.44 -$0.06
03/18/2024 Q4 -- -- -$2.32 -$3.35 $1.03
11/09/2023 Q3 -- -- -$3.26 -$3.13 -$0.14
08/10/2023 Q2 -- -- -$3.13 -$3.30 $0.17
05/11/2023 Q1 -- -- -$2.90 -$3.27 $0.37
03/30/2023 Q4 -- -- -$3.30 -$3.85 $0.55
11/10/2022 Q3 -- -- -$4.00 -- --
08/11/2022 Q2 -- -- -$4.40 -- --
05/12/2022 Q1 -- -- -$3.80 -- --
03/29/2022 Q4 -- -- -$3.50 -- --
11/04/2021 Q3 -- -- -$3.90 -- --
08/05/2021 Q2 -- -- -$4.50 -- --
05/06/2021 Q1 -- -- -$2.90 -- --
03/01/2021 Q4 -- -- -$3.90 -- --
11/05/2020 Q3 -- -- -$3.10 -- --
08/10/2020 Q2 -- -- -$3.60 -- --
05/28/2020 Q1 -- -- -$3.10 -- --
03/12/2020 Q4 -- -- -$3.00 -- --
11/07/2019 Q3 -- -- -$2.50 -- --
08/08/2019 Q2 -- -- -$2.30 -- --
05/08/2019 Q1 -- -- -$2.30 -- --
03/06/2019 Q4 -- -- -$2.40 -- --
11/08/2018 Q3 -- -- -$3.40 -- --
08/08/2018 Q2 -- -- -$3.00 -- --
05/09/2018 Q1 -- -- -$3.00 -- --
03/06/2018 Q4 -- -- -$3.20 -- --
11/08/2017 Q3 -- -- -$3.20 -- --
06/30/2017 Q2 -- -- -$2.70 -- --
03/31/2017 Q1 -- -- -$3.80 -- --
12/31/2016 Q4 -- -- -$5.40 -- --
09/30/2016 Q3 -- -- -$3.50 -- --
06/30/2016 Q2 -- -- -$17.60 -- --
03/31/2016 Q1 -- -- -$5.70 -- --
12/31/2015 Q4 -- -- -$5.45 -- --
09/30/2015 Q3 -- -- -$5.50 -- --
06/30/2015 Q2 -- -- -$3.80 -- --
03/31/2015 Q1 -- -- -$3.80 -- --
12/31/2014 Q4 -- -- -$4.57 -- --

Adverum Biotechnologies Earnings Questions

  • How Much did Adverum Biotechnologies Generate in Revenue Last Quarter?

    Adverum Biotechnologies reported $1M worth of top line sales in its most recent quarter.

  • Did Adverum Biotechnologies Beat Earnings Last Quarter?

    Adverum Biotechnologies announced earnings per share of -$1.30 which represents a beat of analyst forecast a -$1.30 per share.

  • Is Adverum Biotechnologies Profitable?

    Adverum Biotechnologies reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Adverum Biotechnologies EPS Next Year?

    Adverum Biotechnologies's earnings are forecast to decrease from -$11.60 per share to -$12.60 per share next year representing a decrease of -57.22%.

  • When is Adverum Biotechnologies's Earnings Date?

    Adverum Biotechnologies's next earnings date is March 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 2.5% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 3% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock